AskNadia: Type 1 Son Coming from Saudi Arabia to America

Dear Nadia, My son was diagnosed with T1 when he was eight years old. He has been living in Saudi Arabia and getting excellent medical care from the time of his diagnosis. He started using an insulin pump at the age of 9. He is now going to Pomona, California and enrolling in intensive English courses. I would like your recommendations for an excellent T1

Read more

AskNadia: Is The FreeStyle Libre CGM Sensor As Accurate as Finger Pricking Blood Glucose Monitors?

Dear Nadia: I have had type-2 diabetes for more than ten years.  I was first enthusiastic about lancing to see my blood sugar levels, but this dropped off.  My doctor checked blood fasting levels about every three months.  Then, she retired. My new doctor is a proponent of A1C testing over lancing.     I recently was referred to an endocrinologist who put me on the

Read more

AskNadia: Getting Anthem Health Insurance to Cover Medtronic’s 670G Insulin Pump Supplies

This column is a request from people and families living with Type 1 diabetes, that is dealing with an insurance company that refuses to adopt industry standards, by paying for insulin pump supplies like their competitors for a medical device upgrade. The upgrade from the Medtronic 630 G insulin pump and supplies to the 670 G pump, offers no additional cost to the insurance company.

Read more

Claudia Graham- Staying Ahead of The Trend

Vice President of Global Access at Dexcom, Claudia Graham not only has type 1 diabetes, but she is someone who is professionally involved with the latest trends in media and medical devices for over two decades. The first time I was introduced to Claudia, she was on a television show. Pat Gallagher was the host and Roche Diabetes Care sponsored the show. Back in the

Read more

Aetna and Medtronic Collaborate to Help Members Better Control Type 2

Beginning this month, Aetna and Medtronic, Inc. will work with doctors in a new program to reach up to 300 fully insured members with uncontrolled type 2 diabetes who may improve their health using insulin pump therapy. Eligible members will receive targeted education, case management, and other patient support to help control blood sugar, which also may lower their healthcare costs. Information gathered from the

Read more

Insulin Injection Port Reaches U.S. Market

Medtronic, Inc. has introduced the i-port Advance®, an FDA-cleared injection port device for people with diabetes, to the U.S. market. About the size of a quarter, the injection port attaches to the skin like a bandage and allows users to receive insulin injections repeatedly in the same spot for up to three days. The port’s advantage to users is that it does not require repeated

Read more

FDA Approves Medtronic’s Artificial Pancreas

The FDA has approved a new, automated artificial pancreas system from Minneapolis-based Medtronic, Inc. The innovative, first-generation system is the first of its kind in the United States, and has the capability to automatically stop insulin delivery when blood glucose levels are either too high or too low. The MiniMed 530G with Enlite sensor is one of many innovations in diabetic treatment options from Medtronic.

Read more